Related Experiment Video

Updated: Apr 2, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.8K

Non-Cutaneous Melanoma: Biology, Clinical Management, Current Therapy, and Future Directions in Treatment

Leanne M Brown1, Kelly Olino2

  • 1Department of Surgery, Yale New Haven Hospital, New Haven, CT 06511, USA; Yale School of Medicine, 310 Cedar Street FMB 130, New Haven, CT 06520, USA.

Surgical Oncology Clinics of North America
|May 24, 2025
PubMed

Insights

Noncutaneous melanoma (NCM) presents treatment challenges due to its location and poor response to therapies. New treatments show promise for ocular melanoma, but mucosal melanoma requires further research.

Area of Science:

  • Oncology
  • Dermatology
  • Ophthalmology

Background:

  • Noncutaneous melanoma (NCM), encompassing ocular and mucosal types, is challenging to treat.
  • Anatomical constraints and limited response to systemic therapies hinder NCM management.
  • Understanding NCM pathogenesis is crucial for effective targeted therapies.

Purpose of the Study:

  • To review current treatment challenges and recent advancements in noncutaneous melanoma.
  • To highlight the need for further research in NCM management.

Main Methods:

  • Literature review of recent research on noncutaneous melanoma.
  • Analysis of novel therapeutic agents and delivery platforms.

Main Results:

  • Ocular melanoma shows improved survival with agents like tebentafusp and liver-directed therapies.
  • Mucosal melanoma therapies remain limited, indicating an unmet clinical need.
  • Molecular drivers of NCM are identified, but targeted therapy response is variable.

Conclusions:

  • Novel treatments offer new hope for ocular melanoma patients.
  • Significant research and clinical trials are essential to improve mucosal melanoma outcomes.
  • Further understanding of NCM pathogenesis is critical for developing better management strategies.
Keywords:
Mucosal melanomaNoncutaneous melanomaOcular melanoma

More Related Videos

A Melanoma Patient-Derived Xenograft Model07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

13.4K
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.7K

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
4.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K